Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 749 of 1,261
  1. US 9056907

    Human domain antibodies against components of the human insulin-like growth factor (IGF) system

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted
  2. US 9055765

    Dietary compositions and related methods of use

    Northwestern University · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted
  3. US 9056154

    High-yield activation of polymer surfaces for covalent attachment of molecules

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted
  4. US 2015158906

    Method of Purifying Therapeutic Proteins

    CSL LTD [AU] · Granted Jun 11, 2015 · Expires Jun 6, 2035

    granted
  5. US 9050263

    Pharmaceutical compositions for the treatment of Helicobacter pylori

    RedHill Biopharma Ltd. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  6. US 9051271

    Substituted pyridine derivatives useful in the treatment of cancer

    UNITED ARAB EMIRATES UNIVERSITY · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  7. US 9051379

    Sp1 polypeptides, modified Sp1 polypeptides and uses thereof

    Fulcrum SP Ltd. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  8. US 9050311

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  9. US 9050285

    Recombinant bacterium capable of eliciting an immune response against Streptococcus pneumoniae

    The United States of America National Institutes of Health (NH), U.S. Dept. of Health and Human Services (DHHS) · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  10. US 9051270

    Pyridone amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  11. US 9050298

    Method of treating ischemia/reperfusion injuries to a heart with netrin-1

    The Regents of the University of California · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  12. US 9050302

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Jazz Pharmaceuticals Ireland Limited · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  13. US 9050300

    Surgical applications for BMP binding protein

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  14. US 9050299

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  15. US 9050343

    Combination of pimavanserin and risperidone for the treatment of psychosis

    ACADIA Pharmaceuticals Inc. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  16. US 9050372

    High molecular weight derivatives of vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  17. US 9051249

    Benzylamine derivatives as inhibitors of plasma kallikrein

    KalVista Pharmaceuticals Limited · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  18. US 9050376

    Conjugates of synthetic TLR agonists and uses therefor

    The Regents of the University of California · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  19. US 9050378

    N2S2 chelate-targeting ligand conjugates

    The Board of Regents of the University of Texas System · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  20. US 9051303

    Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-YL)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan-2-YL)-1H-indol-5-YL)-cyclopropanecarboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  21. US 9051312

    Methods of treating dyskinesia and related disorders

    Melior Discovery, Inc. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  22. US 9051324

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  23. US 9051342

    Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation related diseases

    PTC THERAPEUTICS, INC. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  24. US 9051319

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.